To determine the percentage of time a Part B rebatable drug was currently in shortage during the calendar quarter, as proposed in 427.401(b)(3), CMS would count the number of days such drug is currently in shortage in a calendar quarter and divide by the total number of days in that calendar quarter
Finally, the Japanese experience points to the potential to achieve dramatic reductions in smoking without the planning or approval of government regulators
HHS Publication No
For example, characterising flavours other than tobacco have been banned in cigarettes, but not in (most) other tobacco and nicotine products, in Europe, Canada and the USA.19 75 While adults may use ENDS to quit or reduce smoking,73 76 77 adolescents and young adults often mention novelty and curiosity.7678 Flavours, in particular, attract both youth and adults to use ENDS79 80
or (ii) The approved labeling includes the indication for use in conjunction with immunosuppressive drugs to prevent or treat rejection of a transplanted organ or tissue
